Bhp Group Limited Income Statement Quarterly
BHP
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2022) IV. Quarter |
0 III. Quarter |
0 II. Quarter |
0 I. Quarter |
(Jun 30 2021) IV. Quarter |
Total Revenue |
65,098.00 |
0.00 |
0.00 |
0.00 |
60,817.00 |
Cost of Revenues |
- |
- |
- |
- |
- |
Gross
Profit |
65,098.00 |
0.00 |
0.00 |
0.00 |
60,817.00 |
Selling, Administration, Marketing |
- |
- |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
31,961.00 |
- |
- |
- |
36,216.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
30,992.00 |
- |
- |
- |
34,911.00 |
Operating income/-loss
|
34,106.00 |
- |
- |
- |
25,906.00 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-21,431.00 |
- |
- |
- |
-20,894.00 |
Total costs & expenses |
9,561.00 |
0.00 |
0.00 |
0.00 |
36,216.00 |
Income /-loss before income taxes |
55,537.00 |
0.00 |
0.00 |
0.00 |
24,601.00 |
Income taxes expenses/-benefit |
10,737.00 |
- |
- |
- |
11,150.00 |
Income after income taxes |
33,055.00 |
0.00 |
0.00 |
0.00 |
13,451.00 |
Net income/-loss
of other equity |
-11,745.00 |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
33,055.00 |
0.00 |
0.00 |
0.00 |
13,451.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
33,055.00 |
0.00 |
0.00 |
0.00 |
13,451.00 |
Noncontrolling interests |
2,155.00 |
- |
- |
- |
2,147.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
30,900.00 |
0.00 |
0.00 |
0.00 |
11,304.00 |
EBIT |
55,537.00 |
0.00 |
0.00 |
0.00 |
24,601.00 |
EBITD |
55,537.00 |
0.00 |
0.00 |
0.00 |
24,601.00 |
EBITDA |
55,537.00 |
0.00 |
0.00 |
0.00 |
24,601.00 |
Per
Share (GAAP Quarterly, in $) |
(Jun 30 2022) IV. Quarter |
0 III. Quarter |
0 II. Quarter |
0 I. Quarter |
(Jun 30 2021) IV. Quarter |
Basic EPS (excl. extra
items) |
4.00 |
0.00 |
0.00 |
0.00 |
2.24 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
4.00 |
0.00 |
0.00 |
0.00 |
2.24 |
Basic shares outstanding (Mill.
of Units) |
7,725.00 |
0.00 |
0.00 |
0.00 |
5,057.72 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
6.09 |
0.00 |
0.00 |
0.00 |
2.23 |
Diluted average shares (Mill.
of Units) |
5,071.39 |
5,071.39 |
5,071.39 |
5,071.39 |
5,069.06 |
Dividend per share |
- |
- |
- |
- |
- |
|
|